|
1698
|
A 770041
|
Orally active src-family selective lck inhibitor |
€135.00
|
|
1378
|
AG 490
|
JAK2 inhibitor |
€65.00
|
|
2031
|
AIM 100
|
Specific inhibitor of Ack1 tyrosine kinase (also known as TNK2) |
€95.00
|
|
2219
|
AT 9283
|
Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) |
€85.00
|
|
2226
|
AVL 292
|
Potent, selective, covalent BTK inhibitor |
€120.00
|
|
1778
|
AZ 960
|
JAK2 inhibitor |
€95.00
|
|
1456
|
AZD 0530 difumarate
|
Inhibitor of SRC and ABL tyrosine kinases |
€105.00
|
|
1955
|
Baricitinib
|
Inhibitor of JAK1 and JAK2 |
€105.00
|
|
2018
|
CGI 1746
|
Inhibitor of Bruton's tyrosine kinase (BTK) |
€95.00
|
|
2097
|
CGP 77675
|
Src Family kinase (SFK) inhibitor |
€90.00
|
|
1338
|
CP 690550
|
JAK3 inhibitor |
€70.00
|
|
1681
|
CYT 387
|
JAK1 and JAK2 inhibitor |
€90.00
|
|
2574
|
Defactinib
|
Orally available second generation inhibitor of FAK and PYK2 |
€95.00
|
|
1843
|
JAK2 inhibitor 13
|
JAK2 inhibitor |
€115.00
|
|
2554
|
LY 2784544
|
Potent, selective and ATP-competitive inhibitor of mutated janus kinase 2 (JAK2V617F) |
€95.00
|